Hamilton Lane Advisors LLC Vir Biotechnology, Inc. Transaction History

Hamilton Lane Advisors LLC

  • $122 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022
SELL
$21.19 - $40.01 $170,176 - $321,320
-8,031 Closed
0 $0
Q4 2021

Jan 28, 2022
BUY
$30.97 - $54.03 $248,720 - $433,914
8,031 New
8,031 $336,000
Q3 2021

Oct 14, 2021
SELL
$34.9 - $54.54 $597,243 - $933,343
-17,113 Closed
0 $0
Q2 2021

Jul 20, 2021
BUY
$38.75 - $51.0 $663,128 - $872,763
17,113 New
17,113 $809,000

Others Institutions Holding VIR

# of Institutions
225
Shares Held
87.5M
Call Options Held
231K
Put Options Held
132K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $993M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email